The toxic effect on leukocyte lineage of antimicrobial therapy in urinary and respiratory infections
Antimicrobials are widely used in infectious diseases. Only the timely intervention will contribute to the positive outcome of the disease. Unjustified use of antimicrobial prophylaxis may have adverse effects, i.e., result in bacterial resistance to existing antimicrobials, as well as toxic effects...
Gespeichert in:
Veröffentlicht in: | Medicinski arhiv 2014-06, Vol.68 (3), p.167-169 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 169 |
---|---|
container_issue | 3 |
container_start_page | 167 |
container_title | Medicinski arhiv |
container_volume | 68 |
creator | Junuzovic, Dzelaludin Zunic, Lejla Dervisefendic, Melika Skopljak, Amira Pasagic, Almir Masic, Izet |
description | Antimicrobials are widely used in infectious diseases. Only the timely intervention will contribute to the positive outcome of the disease. Unjustified use of antimicrobial prophylaxis may have adverse effects, i.e., result in bacterial resistance to existing antimicrobials, as well as toxic effects on leukocyte lineage and other parameters of the blood.
The goal of this study was to confirm that the antimicrobial therapy of urinary, gynecological and respiratory infections has a toxic effect on leukocyte lineage. Followed by lowered immunity and the emergence of risk for health complications especially in oncology and other immunodeficient patients for whom to apply pharmacotherapy it is necessary to have adequate immunity, or white blood cell count that is greater than 4.0x10(9)/L.
A prospective-retrospective study was conducted on a sample of 30 patients in a Primary Health Care Center in Gracanica during the period from March 01, 2013 until April 01, 2014. Testing of this sample was conducted by survey on health status and treatment, or on taking of antimicrobial therapy and other treatment regimens, with the referral diagnosis and determination of leukocytes count in by hematology counter SYSMEX. Results of leukocytes below and close to the lower reference values were statistically analyzed by Students t-test.
Mean WBC count in the group treated with antimicrobial therapy was 3.687±0.83 x10(9)/L, in the group which during repeated infection did not use the antimicrobial therapy 5.09±1.04 x10(9)/L, and in the control group of healthy subjects 7.178±1.038 x10(9)/L. Statistical analysis with Student's t test indicate highly significant differences between group of patients that used antimicrobial therapy with the group of patient that did not used antimicrobial during repeated infection (t=6.091; p=0.0001), as well as significant differences in mean WBC count of both of these groups and the controls (t=4.984; p=0.0001, and t=8.402, p=0.0001).
Use of antimicrobial drugs leads to serious toxic reactions, or leukopenia. Indications for the use of antimicrobial therapy must be strictly followed, because banal, frequent infections are not indication for antimicrobial therapy. It is necessary to know the types of infection causes. Important is the proper and timely selection of antimicrobial therapy. When selecting the drug we should bear in mind its antimicrobial activity, pharmacokinetic and toxic properties, as well as patient health status. Possible is als |
doi_str_mv | 10.5455/medarh.2014.68.167-169 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4240340</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3375287981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3579-bfac71f154da27a41ee6199f37722b24cdd9b5e48f3f130043dcdbd2c1488b753</originalsourceid><addsrcrecordid>eNpVUV2LFDEQDKJ46-pfOAI-z16-M3kR5PBUOPDlBN9CJunc5pxN1syM3P57M-x5KHTTD11dXVQhdEnJTgoprw4QXN3vGKFip_odVbqjyrxAG2p61Umj6Eu0IVySjhrz4wK9maYHQqTRzLxGF0xK1UumNijc7QHP5TF5DDGCn3HJeITlZ_GnGfCYMrh7wCVil-d0SL6WIbkRz3uo7njCKeOlpuzqqQECrjAdU3Vzqetq5UslT2_Rq-jGCd49zS36fvPp7vpLd_vt89frj7ed51KbbojOaxqpFMEx7QQFUE195FozNjDhQzCDBNFHHiknRPDgwxCYp6LvBy35Fn048x6XoRnkIc_VjfZY06EJtMUl-_8mp729L7-tYILwVlv0_omgll8LTLN9KEvNTbOlq-1SGL2i1BnVzJimCvH5AyV2hdlzOnZNx6retnRam3Z4-a--57O_cfA_iEGQXQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1545554970</pqid></control><display><type>article</type><title>The toxic effect on leukocyte lineage of antimicrobial therapy in urinary and respiratory infections</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Junuzovic, Dzelaludin ; Zunic, Lejla ; Dervisefendic, Melika ; Skopljak, Amira ; Pasagic, Almir ; Masic, Izet</creator><creatorcontrib>Junuzovic, Dzelaludin ; Zunic, Lejla ; Dervisefendic, Melika ; Skopljak, Amira ; Pasagic, Almir ; Masic, Izet</creatorcontrib><description>Antimicrobials are widely used in infectious diseases. Only the timely intervention will contribute to the positive outcome of the disease. Unjustified use of antimicrobial prophylaxis may have adverse effects, i.e., result in bacterial resistance to existing antimicrobials, as well as toxic effects on leukocyte lineage and other parameters of the blood.
The goal of this study was to confirm that the antimicrobial therapy of urinary, gynecological and respiratory infections has a toxic effect on leukocyte lineage. Followed by lowered immunity and the emergence of risk for health complications especially in oncology and other immunodeficient patients for whom to apply pharmacotherapy it is necessary to have adequate immunity, or white blood cell count that is greater than 4.0x10(9)/L.
A prospective-retrospective study was conducted on a sample of 30 patients in a Primary Health Care Center in Gracanica during the period from March 01, 2013 until April 01, 2014. Testing of this sample was conducted by survey on health status and treatment, or on taking of antimicrobial therapy and other treatment regimens, with the referral diagnosis and determination of leukocytes count in by hematology counter SYSMEX. Results of leukocytes below and close to the lower reference values were statistically analyzed by Students t-test.
Mean WBC count in the group treated with antimicrobial therapy was 3.687±0.83 x10(9)/L, in the group which during repeated infection did not use the antimicrobial therapy 5.09±1.04 x10(9)/L, and in the control group of healthy subjects 7.178±1.038 x10(9)/L. Statistical analysis with Student's t test indicate highly significant differences between group of patients that used antimicrobial therapy with the group of patient that did not used antimicrobial during repeated infection (t=6.091; p=0.0001), as well as significant differences in mean WBC count of both of these groups and the controls (t=4.984; p=0.0001, and t=8.402, p=0.0001).
Use of antimicrobial drugs leads to serious toxic reactions, or leukopenia. Indications for the use of antimicrobial therapy must be strictly followed, because banal, frequent infections are not indication for antimicrobial therapy. It is necessary to know the types of infection causes. Important is the proper and timely selection of antimicrobial therapy. When selecting the drug we should bear in mind its antimicrobial activity, pharmacokinetic and toxic properties, as well as patient health status. Possible is also the application of preventive medicine as well as other manner of solving infection.</description><identifier>ISSN: 0350-199X</identifier><identifier>EISSN: 1986-5961</identifier><identifier>DOI: 10.5455/medarh.2014.68.167-169</identifier><identifier>PMID: 25568526</identifier><language>eng</language><publisher>Bosnia and Herzegovina: Academy of Medical Sciences of Bosnia and Herzegovina</publisher><subject>Anti-Infective Agents - adverse effects ; Anti-Infective Agents - therapeutic use ; Bosnia and Herzegovina ; Drug Resistance, Microbial - drug effects ; Female ; Humans ; Leukocyte Count ; Leukopenia - chemically induced ; Male ; Original ; Prospective Studies ; Respiratory Tract Infections - blood ; Respiratory Tract Infections - drug therapy ; Respiratory Tract Infections - immunology ; Retrospective Studies ; Urinary Tract Infections - blood ; Urinary Tract Infections - drug therapy ; Urinary Tract Infections - immunology ; Young Adult</subject><ispartof>Medicinski arhiv, 2014-06, Vol.68 (3), p.167-169</ispartof><rights>Copyright Academy of Medical Sciences of Bosnia and Herzegovina 2014</rights><rights>Copyright: © AVICENA 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3579-bfac71f154da27a41ee6199f37722b24cdd9b5e48f3f130043dcdbd2c1488b753</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240340/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240340/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25568526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Junuzovic, Dzelaludin</creatorcontrib><creatorcontrib>Zunic, Lejla</creatorcontrib><creatorcontrib>Dervisefendic, Melika</creatorcontrib><creatorcontrib>Skopljak, Amira</creatorcontrib><creatorcontrib>Pasagic, Almir</creatorcontrib><creatorcontrib>Masic, Izet</creatorcontrib><title>The toxic effect on leukocyte lineage of antimicrobial therapy in urinary and respiratory infections</title><title>Medicinski arhiv</title><addtitle>Med Arch</addtitle><description>Antimicrobials are widely used in infectious diseases. Only the timely intervention will contribute to the positive outcome of the disease. Unjustified use of antimicrobial prophylaxis may have adverse effects, i.e., result in bacterial resistance to existing antimicrobials, as well as toxic effects on leukocyte lineage and other parameters of the blood.
The goal of this study was to confirm that the antimicrobial therapy of urinary, gynecological and respiratory infections has a toxic effect on leukocyte lineage. Followed by lowered immunity and the emergence of risk for health complications especially in oncology and other immunodeficient patients for whom to apply pharmacotherapy it is necessary to have adequate immunity, or white blood cell count that is greater than 4.0x10(9)/L.
A prospective-retrospective study was conducted on a sample of 30 patients in a Primary Health Care Center in Gracanica during the period from March 01, 2013 until April 01, 2014. Testing of this sample was conducted by survey on health status and treatment, or on taking of antimicrobial therapy and other treatment regimens, with the referral diagnosis and determination of leukocytes count in by hematology counter SYSMEX. Results of leukocytes below and close to the lower reference values were statistically analyzed by Students t-test.
Mean WBC count in the group treated with antimicrobial therapy was 3.687±0.83 x10(9)/L, in the group which during repeated infection did not use the antimicrobial therapy 5.09±1.04 x10(9)/L, and in the control group of healthy subjects 7.178±1.038 x10(9)/L. Statistical analysis with Student's t test indicate highly significant differences between group of patients that used antimicrobial therapy with the group of patient that did not used antimicrobial during repeated infection (t=6.091; p=0.0001), as well as significant differences in mean WBC count of both of these groups and the controls (t=4.984; p=0.0001, and t=8.402, p=0.0001).
Use of antimicrobial drugs leads to serious toxic reactions, or leukopenia. Indications for the use of antimicrobial therapy must be strictly followed, because banal, frequent infections are not indication for antimicrobial therapy. It is necessary to know the types of infection causes. Important is the proper and timely selection of antimicrobial therapy. When selecting the drug we should bear in mind its antimicrobial activity, pharmacokinetic and toxic properties, as well as patient health status. Possible is also the application of preventive medicine as well as other manner of solving infection.</description><subject>Anti-Infective Agents - adverse effects</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Bosnia and Herzegovina</subject><subject>Drug Resistance, Microbial - drug effects</subject><subject>Female</subject><subject>Humans</subject><subject>Leukocyte Count</subject><subject>Leukopenia - chemically induced</subject><subject>Male</subject><subject>Original</subject><subject>Prospective Studies</subject><subject>Respiratory Tract Infections - blood</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Respiratory Tract Infections - immunology</subject><subject>Retrospective Studies</subject><subject>Urinary Tract Infections - blood</subject><subject>Urinary Tract Infections - drug therapy</subject><subject>Urinary Tract Infections - immunology</subject><subject>Young Adult</subject><issn>0350-199X</issn><issn>1986-5961</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpVUV2LFDEQDKJ46-pfOAI-z16-M3kR5PBUOPDlBN9CJunc5pxN1syM3P57M-x5KHTTD11dXVQhdEnJTgoprw4QXN3vGKFip_odVbqjyrxAG2p61Umj6Eu0IVySjhrz4wK9maYHQqTRzLxGF0xK1UumNijc7QHP5TF5DDGCn3HJeITlZ_GnGfCYMrh7wCVil-d0SL6WIbkRz3uo7njCKeOlpuzqqQECrjAdU3Vzqetq5UslT2_Rq-jGCd49zS36fvPp7vpLd_vt89frj7ed51KbbojOaxqpFMEx7QQFUE195FozNjDhQzCDBNFHHiknRPDgwxCYp6LvBy35Fn048x6XoRnkIc_VjfZY06EJtMUl-_8mp729L7-tYILwVlv0_omgll8LTLN9KEvNTbOlq-1SGL2i1BnVzJimCvH5AyV2hdlzOnZNx6retnRam3Z4-a--57O_cfA_iEGQXQ</recordid><startdate>201406</startdate><enddate>201406</enddate><creator>Junuzovic, Dzelaludin</creator><creator>Zunic, Lejla</creator><creator>Dervisefendic, Melika</creator><creator>Skopljak, Amira</creator><creator>Pasagic, Almir</creator><creator>Masic, Izet</creator><general>Academy of Medical Sciences of Bosnia and Herzegovina</general><general>AVICENA, d.o.o., Sarajevo</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>201406</creationdate><title>The toxic effect on leukocyte lineage of antimicrobial therapy in urinary and respiratory infections</title><author>Junuzovic, Dzelaludin ; Zunic, Lejla ; Dervisefendic, Melika ; Skopljak, Amira ; Pasagic, Almir ; Masic, Izet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3579-bfac71f154da27a41ee6199f37722b24cdd9b5e48f3f130043dcdbd2c1488b753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Anti-Infective Agents - adverse effects</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Bosnia and Herzegovina</topic><topic>Drug Resistance, Microbial - drug effects</topic><topic>Female</topic><topic>Humans</topic><topic>Leukocyte Count</topic><topic>Leukopenia - chemically induced</topic><topic>Male</topic><topic>Original</topic><topic>Prospective Studies</topic><topic>Respiratory Tract Infections - blood</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Respiratory Tract Infections - immunology</topic><topic>Retrospective Studies</topic><topic>Urinary Tract Infections - blood</topic><topic>Urinary Tract Infections - drug therapy</topic><topic>Urinary Tract Infections - immunology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Junuzovic, Dzelaludin</creatorcontrib><creatorcontrib>Zunic, Lejla</creatorcontrib><creatorcontrib>Dervisefendic, Melika</creatorcontrib><creatorcontrib>Skopljak, Amira</creatorcontrib><creatorcontrib>Pasagic, Almir</creatorcontrib><creatorcontrib>Masic, Izet</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicinski arhiv</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Junuzovic, Dzelaludin</au><au>Zunic, Lejla</au><au>Dervisefendic, Melika</au><au>Skopljak, Amira</au><au>Pasagic, Almir</au><au>Masic, Izet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The toxic effect on leukocyte lineage of antimicrobial therapy in urinary and respiratory infections</atitle><jtitle>Medicinski arhiv</jtitle><addtitle>Med Arch</addtitle><date>2014-06</date><risdate>2014</risdate><volume>68</volume><issue>3</issue><spage>167</spage><epage>169</epage><pages>167-169</pages><issn>0350-199X</issn><eissn>1986-5961</eissn><abstract>Antimicrobials are widely used in infectious diseases. Only the timely intervention will contribute to the positive outcome of the disease. Unjustified use of antimicrobial prophylaxis may have adverse effects, i.e., result in bacterial resistance to existing antimicrobials, as well as toxic effects on leukocyte lineage and other parameters of the blood.
The goal of this study was to confirm that the antimicrobial therapy of urinary, gynecological and respiratory infections has a toxic effect on leukocyte lineage. Followed by lowered immunity and the emergence of risk for health complications especially in oncology and other immunodeficient patients for whom to apply pharmacotherapy it is necessary to have adequate immunity, or white blood cell count that is greater than 4.0x10(9)/L.
A prospective-retrospective study was conducted on a sample of 30 patients in a Primary Health Care Center in Gracanica during the period from March 01, 2013 until April 01, 2014. Testing of this sample was conducted by survey on health status and treatment, or on taking of antimicrobial therapy and other treatment regimens, with the referral diagnosis and determination of leukocytes count in by hematology counter SYSMEX. Results of leukocytes below and close to the lower reference values were statistically analyzed by Students t-test.
Mean WBC count in the group treated with antimicrobial therapy was 3.687±0.83 x10(9)/L, in the group which during repeated infection did not use the antimicrobial therapy 5.09±1.04 x10(9)/L, and in the control group of healthy subjects 7.178±1.038 x10(9)/L. Statistical analysis with Student's t test indicate highly significant differences between group of patients that used antimicrobial therapy with the group of patient that did not used antimicrobial during repeated infection (t=6.091; p=0.0001), as well as significant differences in mean WBC count of both of these groups and the controls (t=4.984; p=0.0001, and t=8.402, p=0.0001).
Use of antimicrobial drugs leads to serious toxic reactions, or leukopenia. Indications for the use of antimicrobial therapy must be strictly followed, because banal, frequent infections are not indication for antimicrobial therapy. It is necessary to know the types of infection causes. Important is the proper and timely selection of antimicrobial therapy. When selecting the drug we should bear in mind its antimicrobial activity, pharmacokinetic and toxic properties, as well as patient health status. Possible is also the application of preventive medicine as well as other manner of solving infection.</abstract><cop>Bosnia and Herzegovina</cop><pub>Academy of Medical Sciences of Bosnia and Herzegovina</pub><pmid>25568526</pmid><doi>10.5455/medarh.2014.68.167-169</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0350-199X |
ispartof | Medicinski arhiv, 2014-06, Vol.68 (3), p.167-169 |
issn | 0350-199X 1986-5961 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4240340 |
source | MEDLINE; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Anti-Infective Agents - adverse effects Anti-Infective Agents - therapeutic use Bosnia and Herzegovina Drug Resistance, Microbial - drug effects Female Humans Leukocyte Count Leukopenia - chemically induced Male Original Prospective Studies Respiratory Tract Infections - blood Respiratory Tract Infections - drug therapy Respiratory Tract Infections - immunology Retrospective Studies Urinary Tract Infections - blood Urinary Tract Infections - drug therapy Urinary Tract Infections - immunology Young Adult |
title | The toxic effect on leukocyte lineage of antimicrobial therapy in urinary and respiratory infections |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T14%3A14%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20toxic%20effect%20on%20leukocyte%20lineage%20of%20antimicrobial%20therapy%20in%20urinary%20and%20respiratory%20infections&rft.jtitle=Medicinski%20arhiv&rft.au=Junuzovic,%20Dzelaludin&rft.date=2014-06&rft.volume=68&rft.issue=3&rft.spage=167&rft.epage=169&rft.pages=167-169&rft.issn=0350-199X&rft.eissn=1986-5961&rft_id=info:doi/10.5455/medarh.2014.68.167-169&rft_dat=%3Cproquest_pubme%3E3375287981%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1545554970&rft_id=info:pmid/25568526&rfr_iscdi=true |